Paula M Chilton

Currently studies low-toxicity adjuvants for their ability to promote specific immune responses in low-inflammatory conditions. With her work is currently focused on vaccine adjuvants, the use of naturally-occurring forms of immune stimulatory molecules to counter inflammatory conditions is of keen interest and is directly applicable to attenuating immune responses after infection, trauma or stress-related insult.